Intralesional Immunotherapy Agents Show Promising Outcomes in Plantar Warts
Immunotherapy using zinc sulfate and vitamin D3 may be promising treatment options for plantar warts.
All articles by Dermatology Advisor Contributing Writer
Content-Valid Patient-Reported Outcome Measure Developed for Alopecia Areata
A novel patient-reported outcome measure allows scalp hair loss to be characterized into clinically meaningful gradations from 0% to 100% missing scalp hair.
Infection Rates Similar for Biologic Agents vs Nonbiologic Agents in Children With Psoriasis
Risk for infection was not higher in pediatric patients with psoriasis treated with biologic agents compared with those treated with nonbiologic immunomudulators.
Anxiety and Depression Higher in Patients With Acne Vulgaris
As patients with acne often have psychological comorbidities a multidisciplinary approach may yield optimal treatment.
Antibiotic Exposure in Pregnancy Increases Risk for Childhood Atopic Dermatitis
Exposure to several antibiotics during pregnancy may be linked to the development of atopic dermatitis in offspring within the first 24 months of life.
Bacterial Lysate Application in Infancy Does Not Affect Allergy Development
The effect of bacterial lysate applied orally from the 2nd until 7th months of life on the prevalence of allergic diseases at school age was evaluated and found not to influence the development of certain skin or allergic disease.
HIDRAscore Measures Severity of HS, Includes Patient Reports
A novel scoring system for hidradenitis suppurativa severity that includes a patient-reported component has been developed.
Poorer Sleep Quality Associated With Asthma Plus Atopic Dermatitis
Children with asthma and atopic dermatitis experience worse sleep and lung function outcomes compared with children with asthma alone.
Systematic Review of Eczema in Plaque Psoriasis Treated With Biologic Agents
Atopic eczema is potentially under recognized in patients with plaque psoriasis undergoing biologic therapy and can have a significant effect on patient management.
Findings from Meta-Analysis on Imiquimod Treatment for BCC Misleading
The purported benefits of imiquimod for the treatment of basal cell carcinoma are disputed in a critical review that finds numerous study flaws.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...